As of 2025-07-11, the EV/EBITDA ratio of agilon health Inc (AGL) is -3.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 854.21 mil USD. AGL's TTM EBITDA according to its financial statements is -240.11 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 12.5x | 12.5x |
| Forward P/E multiples | 11.2x - 12.8x | 12.3x |
| Fair Price | (6.54) - (7.00) | (6.95) |
| Upside | -383.1% - -403.2% | -400.7% |
| Date | EV/EBITDA |
| 2025-07-10 | -3.56 |
| 2025-07-09 | -3.52 |
| 2025-07-08 | -3.70 |
| 2025-07-07 | -3.59 |
| 2025-07-03 | -3.76 |
| 2025-07-02 | -3.70 |
| 2025-07-01 | -3.68 |
| 2025-06-30 | -3.54 |
| 2025-06-27 | -3.56 |
| 2025-06-26 | -3.56 |
| 2025-06-25 | -3.33 |
| 2025-06-24 | -3.39 |
| 2025-06-23 | -3.28 |
| 2025-06-20 | -3.21 |
| 2025-06-18 | -3.33 |
| 2025-06-17 | -3.20 |
| 2025-06-16 | -3.33 |
| 2025-06-13 | -3.28 |
| 2025-06-12 | -3.35 |
| 2025-06-11 | -3.52 |
| 2025-06-10 | -3.51 |
| 2025-06-09 | -3.51 |
| 2025-06-06 | -3.30 |
| 2025-06-05 | -3.20 |
| 2025-06-04 | -3.35 |
| 2025-06-03 | -3.49 |
| 2025-06-02 | -3.45 |
| 2025-05-30 | -3.40 |
| 2025-05-29 | -3.42 |
| 2025-05-28 | -3.63 |
| 2025-05-27 | -3.42 |
| 2025-05-23 | -3.40 |
| 2025-05-22 | -3.37 |
| 2025-05-21 | -3.63 |
| 2025-05-20 | -3.85 |
| 2025-05-19 | -3.61 |
| 2025-05-16 | -3.80 |
| 2025-05-15 | -3.97 |
| 2025-05-14 | -4.18 |
| 2025-05-13 | -4.23 |
| 2025-05-12 | -4.70 |
| 2025-05-09 | -4.56 |
| 2025-05-08 | -5.13 |
| 2025-05-07 | -5.42 |
| 2025-05-06 | -7.26 |
| 2025-05-05 | -6.68 |
| 2025-05-02 | -6.75 |
| 2025-05-01 | -6.35 |
| 2025-04-30 | -6.92 |
| 2025-04-29 | -6.13 |